Kamada Anti-SARS-CoV-2

Biologic

KKamada, Ltd.

Kamada Anti-SARS-CoV-2 is one of 40 biologic programs targeting Emphysema. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

EmphysemaActive, not recruiting

COVID-19Active, not recruiting

EmphysemaPhase 2/Phase 3

Active, not recruiting

COVID-19Phase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

COVID-19 Vaccine

Moderna

Preclinical

27 2

Aldactone

Pfizer

Preclinical

1 3

Nexavar

Bayer

Preclinical

1 4

Activella

Benadryl

1 6

Aprotinin

Bayer

Preclinical

1 7

Antithrombin-III

Octapharma

Preclinical

1 8

Interferon-Gamma

SSPP Pharmaclon Ltd.

Preclinical

1 9

DAS181

AAnsun Biopharma, Inc.

Preclinical

4 10

C21

VVicore Pharma AB

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Emphysema1 trial

International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema

Completed·KKamada, Ltd.·Phase 2/3·NCT01217671·168 enrolled

COVID-191 trial

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19

Completed·KKamada, Ltd.·Phase 1/2·NCT04550325·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Kamada Anti-SARS-CoV-2. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Kamada Anti-SARS-CoV-2 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Kamada Anti-SARS-CoV-2. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Kamada, Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Company: KKamada, Ltd.

Kamada Anti-SARS-CoV-2

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Emphysema1 trial

COVID-191 trial

References

Drug Info

Quick Facts

Related News